Silverback Therapeutics Inc
NASDAQ:SBTX 3:59:41 PM EDT
Silverback Therapeutics, Inc. Stock, NASDAQ:SBTX
500 Fairview Avenue North, Suite 600, Seattle, Washington 98109
United States of America
Phone: +1.206.456.2900
Number of Employees:
Description
Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson on January 4, 2016 and is headquartered in Seattle, WA.